PREvention of VENous Thromboembolism In Hemorrhagic Stroke Patients (PREVENTIHS)
Sponsor: University Of Perugia
Terminated
The trial has been terminated prematurely after the randomization of 73 patients due to a lack of funding.
Other terminated trials from University Of Perugia
Other Deep Venous Thrombosis trials with similar outcome
Listed as NCT01573169, this PHASE3 trial focuses on Deep Venous Thrombosis and Hemorrhagic Stroke and remains terminated or withdrawn. Sponsored by University Of Perugia, it has been updated 11 times since 2012, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE3
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE3
-
Dec 2021 — Dec 2022 [monthly]
Terminated PHASE3
▶ Show 6 earlier versions
-
Oct 2021 — Dec 2021 [monthly]
Terminated PHASE3
Status: Unknown Status → Terminated
-
Jan 2021 — Oct 2021 [monthly]
Unknown Status PHASE3
Status: Recruiting → Unknown Status
-
Jun 2018 — Jan 2021 [monthly]
Recruiting PHASE3
-
Oct 2017 — Jun 2018 [monthly]
Recruiting PHASE3
Status: Suspended → Recruiting
-
Aug 2017 — Oct 2017 [monthly]
Suspended PHASE3
-
Jan 2017 — Aug 2017 [monthly]
Suspended PHASE3
First recorded
May 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Of Perugia
For direct contact, visit the study record on ClinicalTrials.gov .